ArticleInternal medicine (Tokyo, Japan)2017

The Assessment of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Glucocorticoid-induced Diabetes by Continuous Glucose Monitoring.

Yusuke Yata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.